+Compare
GKOS
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
3.46B

GKOS Glaukos Corp Forecast, Technical & Fundamental Analysis

an ophthalmic medical device company

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for GKOS with price predictions
08:00 PM EDT Oct 02, 2023

GKOS sees MACD Histogram just turned negative

GKOS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 29, 2023. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 02, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on GKOS as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

GKOS moved below its 50-day moving average on October 02, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

GKOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 232 cases where GKOS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GKOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GKOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.077) is normal, around the industry mean (24.901). P/E Ratio (0.000) is within average values for comparable stocks, (79.018). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.345). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (11.468) is also within normal values, averaging (58.146).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.24B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -10%. IMTH experienced the highest price growth at 120%, while SDC experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was 39% and the average quarterly volume growth was 86%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 67
SMR Rating: 84
Profit Risk Rating: 89
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

GKOS is expected to report earnings to -55 cents per share on November 08

Glaukos Corp GKOS Stock Earnings Reports
Q3'23
Est.
$-0.55
Q2'23
Beat
by $0.01
Q1'23
Missed
by $0.01
Q4'22
Beat
by $0.02
Q3'22
Beat
by $0.07
The last earnings report on August 02 showed earnings per share of -55 cents, beating the estimate of -56 cents. With 131.43K shares outstanding, the current market capitalization sits at 3.46B.
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
783
Web
https://www.glaukos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NGE8.39-0.01
-0.13%
Global X MSCI Nigeria ETF
FILL25.09-0.15
-0.59%
iShares MSCI Global Energy Producers ETF
DSJA28.36-0.26
-0.90%
Innovator Double Stacker ETF January
RPV71.50-1.27
-1.75%
Invesco S&P 500® Pure Value ETF
VIDI22.08-0.40
-1.77%
Vident International Equity Strategy ETF

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ALC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+0.35%
ALC - GKOS
46%
Loosely correlated
-1.63%
RVTY - GKOS
45%
Loosely correlated
-0.54%
CNMD - GKOS
40%
Loosely correlated
+0.69%
TWST - GKOS
40%
Loosely correlated
-4.28%
COO - GKOS
40%
Loosely correlated
+0.32%
More

Groups containing GKOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+0.35%
medical research
(undefined stocks)
50%
Loosely correlated
-0.79%
medical service
(undefined stocks)
48%
Loosely correlated
-0.63%
Medical Specialties
(undefined stocks)
48%
Loosely correlated
+0.33%
Medical Specialties
(undefined stocks)
48%
Loosely correlated
+0.33%
ophthalmology
(undefined stocks)
21%
Poorly correlated
+0.31%